These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Bilateral corneal ulceration in ocular graft-versus-host disease. Stevenson W, Shikari H, Saboo US, Amparo F, Dana R. Clin Ophthalmol; 2013 Aug 01; 7():2153-8. PubMed ID: 24204119 [Abstract] [Full Text] [Related]
6. Corneal perforation in ocular graft-versus-host disease. Zhang CY, Farooq AV, Harocopos GJ, Sollenberger EL, Hou JH, Bouchard CS, Shieh C, Tran UL, Lubniewski AJ, Huang AJW, Paley GL. Am J Ophthalmol Case Rep; 2021 Dec 01; 24():101224. PubMed ID: 34805617 [Abstract] [Full Text] [Related]
7. Ocular surface evaluation in allogenic hematopoietic stem cell transplantation patients. Vanathi M, Kashyap S, Khan R, Seth T, Mishra P, Mahapatra M, Tandon R. Eur J Ophthalmol; 2014 Dec 01; 24(5):655-66. PubMed ID: 24604604 [Abstract] [Full Text] [Related]
8. Development and validation of a diagnostic model for the identification of chronic ocular graft-versus-host disease (oGVHD). Shen Z, Hu B, Tao L, Ma J, Peng R, Zhao Y, Hong J. Front Med (Lausanne); 2023 Dec 01; 10():1277194. PubMed ID: 37964878 [Abstract] [Full Text] [Related]
9. Ocular graft versus host disease in allogenic haematopoetic stem cell transplantation in a tertiary care centre in India. Khan R, Nair S, Seth T, Mishra P, Mahapatra M, Agarwal T, Tandon R, Vanathi M. Indian J Med Res; 2015 Nov 01; 142(5):543-8. PubMed ID: 26658588 [Abstract] [Full Text] [Related]
10. Biomarkers in Ocular Graft-Versus-Host Disease: Implications for the Involvement of B Cells. Shen Z, Ma J, Peng R, Hu B, Zhao Y, Liu S, Hong J. Transplant Cell Ther; 2022 Nov 01; 28(11):749.e1-749.e7. PubMed ID: 35914728 [Abstract] [Full Text] [Related]
11. Dry eye disease and risk factors for corneal complications in chronic ocular graft-versus-host disease. Kate A, Singh S, Das AV, Basu S. Indian J Ophthalmol; 2023 Apr 01; 71(4):1538-1544. PubMed ID: 37026297 [Abstract] [Full Text] [Related]
13. Posterior segment complications and the risk factors after allogeneic hematopoietic stem cell transplantation. Yang B, Wu S, Yu S, Liang X, Liu Q, Huang F, Liang L. Eye (Lond); 2023 Jun 01; 37(9):1816-1821. PubMed ID: 36115883 [Abstract] [Full Text] [Related]
14. Corneal Descemetocele Management with Multi-Layer Amniotic Membrane Transplantation in an Ocular Graft-versus-Host Disease Case. He Y, Wong H, Gu J, Lin L. Medicina (Kaunas); 2023 Sep 27; 59(10):. PubMed ID: 37893451 [Abstract] [Full Text] [Related]
15. Topical Spironolactone in the Treatment of Ocular Graft-Versus-Host Disease. Wong CW, Yang AA, Liu CY, Watsky MA, Lu X, Le HL, Yee RW. Cureus; 2023 Sep 27; 15(9):e45136. PubMed ID: 37842497 [Abstract] [Full Text] [Related]
17. Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease. Singh RB, Yung A, Coco G, Sinha S, Dohlman TH, Yin J, Dana R. Ocul Surf; 2020 Oct 27; 18(4):731-735. PubMed ID: 32738300 [Abstract] [Full Text] [Related]
18. Assessment of Corneal Epithelial Changes and Related Factors in Ocular Chronic Graft-Versus-Host Disease (GVHD) by in Vivo Confocal Microscopy. Liu S, Peng R, Ma J, Shen Z, Hu B, Zhao Y, Hong J. Ocul Immunol Inflamm; 2024 May 27; 32(4):454-462. PubMed ID: 36758227 [Abstract] [Full Text] [Related]
19. Limbal stem cell transplantation: an evidence-based analysis. Medical Advisory Secretariat. Ont Health Technol Assess Ser; 2008 May 27; 8(7):1-58. PubMed ID: 23074512 [Abstract] [Full Text] [Related]
20. Ocular Involvement in Graft-versus-Host Disease. Tappeiner C, Heiligenhaus A, Dietrich-Ntoukas T. Klin Monbl Augenheilkd; 2024 May 27; 241(5):619-625. PubMed ID: 38262426 [Abstract] [Full Text] [Related] Page: [Next] [New Search]